<DOC>
	<DOCNO>NCT02245256</DOCNO>
	<brief_summary>To test effect low-dose dexmedetomidine lower incidence postoperative delirium liver transplant patient ICU . Single center prospective randomize placebo control clinical trial 0.1mcg/kg/hr dexmedetomidine equivalent amount saline infusion start induction anesthesia liver transplantation continue 48 hour surgery . Outcomes assess 1 week transfer ward , whichever come first .</brief_summary>
	<brief_title>Efficacy Low-dose Dexmedetomidine Prevent Delirium Liver Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Adult patient ( 18years old old ) undergo livingdonor deceaseddonor liver transplantation Pediatric patient ( 18 year ) Pregnancy Patients unresponsive baseline , neurologic deficit baseline , allergic dexmedetomidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>delirium</keyword>
	<keyword>incidence</keyword>
	<keyword>dexmedetomidine</keyword>
</DOC>